Diagnostic, Therapeutic and Reproductive Aspects of Patients With Mullerian Anomalies (MULAN)
Launched by UNIVERSITY HOSPITAL, GHENT · Jan 26, 2021
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "MULAN" is focused on understanding Mullerian anomalies, which are variations in the development of female reproductive organs, including the vagina, uterus, and cervix. The goal of this study is to learn more about how these conditions can affect women’s health, especially regarding reproductive issues and pregnancy complications. Researchers are also looking to identify the best methods for diagnosing these anomalies and the most effective surgical treatments.
To participate in this study, women need to have a uterus and be under the age of 45. Those without a uterus or older than 45 are not eligible. Participants can expect to undergo evaluations that will help researchers gather important information about their condition. This study is currently recruiting, and it aims to improve the understanding and management of Mullerian anomalies, which could lead to better care for women facing these challenges.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women with a uterus
- • presence of a mullerian variation
- • Maximum age 45y
- Exclusion Criteria:
- • women without a uterus
- • aged \>45y
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, East Flanders, Belgium
Patients applied
Trial Officials
Tjalina Hamerlynck
Principal Investigator
University Hospital, Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials